Your Shopping Cart Is Empty
| Report Code: A00294 | Sep 2021 | Pages: 203 | ||
| Tables: 121 | Charts: 38 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Equine Healthcare Market
Request Now !The global equine healthcare market size was valued at $1,206.70 million in 2020, and is projected to reach $2,328.90 million by 2030, registering a CAGR of 6.80% from 2021 to 2030. Equine healthcare includes healthcare services provided to the horses of racing and betting, competitive riding, and leisure. Healthcare includes the routine veterinary care for vaccinations, parasite control, and dental care; grooming and hoof care; and protection from natural elements such as rain, wind, and snow. In addition to properly feeding and exercising one’s horse, other aspects of general care are needed to keep the horse healthy throughout his or her life. Adult horses should have a complete veterinary examination at least once a year. Geriatric horses (older than 20 years old) should see their veterinarian twice a year or more frequently as illness is more common in older animals and can be identified sooner.
The COVID-19 pandemic affected the equine healthcare industry in a negative way similar to various other domestic industries. The complete closure of equine facilities has been especially damaging, as these operations bear significant ongoing expenses with no source of revenue.
The market growth is attributed to factors such as rise in prevalence of equine diseases, increase in equine population, increase in animal health expenditure, rise in demand for use of horses for various purposes, increase in advancements of equine healthcare products, rise in awareness among the population about the importance and benefits of using horses, and surge in demand for pet insurance. However, decline in equine population is expected to hamper the equine healthcare market growth.
The global equine healthcare market is segmented into product type, disease, and distribution channel. Based on product type, the market is categorized into drug, vaccines, and medicated feed additives. Furthermore, drugs are classified into anti-infectives, anti-inflammatory, parasiticides, and others. Vaccines are classified into inactivated, live attenuated, recombinant, and others. Based on disease, the market is divided into influenza, tetanus, equine herpes virus, and others (equine encephalomyelitis, west nile virus, equine rabies, and potomac horse fever). On the basis of distribution channel, it is bifurcated into veterinary hospitals and clinics and retail pharmacies and drug stores. Region-wise, the equine healthcare market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Based on product type, the market is categorized into drug, vaccines, and medicated feed additives. The drug segment dominated the global equine healthcare market in 2020, and is anticipated to continue this trend during the forecast period. The key factors, such as rise in demand for pet insurance, surge in awareness toward effective & advanced drugs and vaccines, and rise in number of cases of equine diseases, may lead to increase in hospital admissions. Launch of effective products, which are tested under clinical trials by the companies, ensures better therapeutic outcomes.
On the basis of disease, the market is segregated into influenza, tetanus, equine herpes virus, and others. At present, the others segment accounts for the majority of market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and surge in demand for pet insurance.
On the basis of distribution channel, the equine healthcare market is segregated into veterinary hospitals and clinics and retail pharmacies and drug stores. At present, the retail pharmacies and drug stores segment accounts for the majority of market share, owing to rise in prevalence of equine diseases in both developed as well as developing countries and growing awareness among the population about the importance and benefits of horse healthcare.
North America is constituted to have the highest market share of the equine healthcare market in 2020, followed by other sectors. The larger share of North America can be attributed to the factors such as ease of availability of the products and services across developing countries and rise in animal health expenditure. Overall, it is projected that the need for equine healthcare in developing and developed regions of North America would rise sharply in the coming years.
Key Benefits For Stakeholders
Equine Healthcare Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT |
|
| By DISEASES |
|
| By DISTRIBUTION CHANNEL |
|
| By Region |
|
| Key Market Players | Land O'Lakes, Inc. (Purina Mills, LLC), Equine Products UK LTD, Vetoquinol S.A., Boehringer Ingelheim International GmbH, Zoetis Inc., Thermo Fisher Scientific Inc. (Affymetrix Inc.), Ceva Santé Animale, Sanofi S.A. (Merial), Elanco Animal Health Inc. (Bayer Animal Health), MERCK & CO., INC.(Merck Animal Health) |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of equine diseases
3.5.1.2.Rise in animal health expenditure
3.5.2.Restraint
3.5.2.1.Decline in global equine population
3.5.3.Opportunities
3.5.3.1.Rise in demand for pet insurance
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on Equine healthcare Market
CHAPTER 4:EQUINE HEALTHCARE MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Drug
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.4.Anti-infectives Drugs
4.2.4.1.Market size and forecast
4.2.5.Anti-Inflammatory Drugs
4.2.5.1.Market size and forecast
4.2.6.Parasiticide Drugs
4.2.6.1.Market size and forecast
4.2.7.Other Drugs
4.2.7.1.Market size and forecast
4.3.Vaccines
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.3.4.Inactivated Vaccines
4.3.4.1.Market size and forecast
4.3.5.Live Attenuated Vaccine
4.3.5.1.Market size and forecast
4.3.6.Recombinant Vaccine
4.3.6.1.Market size and forecast
4.3.7.Other vaccines
4.3.7.1.Market size and forecast
4.4.Medicated feed additives
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:EQUINE HEALTHCARE MARKET, BY DISEASES
5.1.Overview
5.1.1.Market size and forecast
5.2.Influenza
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Tetanus
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Equine Herpes Virus
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Other diseases
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
CHAPTER 6:EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Veterinary Hospitals and Clinics
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Retail pharmacies and Drug Stores
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
CHAPTER 7:EQUINE HEALTHCARE MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.3.1.U.S.
7.2.3.1.1.U.S. Equine Healthcare market, by product type
7.2.3.1.2.U.S. Equine Healthcare market, by diseases
7.2.3.1.3.U.S. Equine Healthcare market, by distribution channel
7.2.3.2.Canada
7.2.3.2.1.Canada Equine Healthcare market, by product type
7.2.3.2.2.Canada Equine Healthcare market, by diseases
7.2.3.2.3.Canada Equine Healthcare market, by distribution channel
7.2.3.3.Mexico
7.2.3.3.1.Mexico Equine Healthcare market, by product type
7.2.3.3.2.Mexico Equine Healthcare market, by diseases
7.2.3.3.3.Mexico Equine Healthcare market, by distribution channel
7.2.4.North America market size and forecast, by product type
7.2.5.North America market size and forecast, by diseases
7.2.6.North America market size and forecast, by distribution channel
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country
7.3.2.1.Germany
7.3.2.1.1.Germany Equine Healthcare market, by product type
7.3.2.1.2.Germany Equine Healthcare market, by diseases
7.3.2.1.3.Germany Equine Healthcare market, by distribution channel
7.3.2.2.France
7.3.2.2.1.France Equine Healthcare market, by product type
7.3.2.2.2.France Equine Healthcare market, by diseases
7.3.2.2.3.France Equine Healthcare market, by distribution channel
7.3.2.3.UK
7.3.2.3.1.UK Equine Healthcare market, by product type
7.3.2.3.2.UK Equine Healthcare market, by diseases
7.3.2.3.3.UK Equine Healthcare market, by distribution channel
7.3.2.4.Italy
7.3.2.4.1.Italy Equine Healthcare market, by product type
7.3.2.4.2.Italy Equine Healthcare market, by diseases
7.3.2.4.3.Italy Equine Healthcare market, by distribution channel
7.3.2.5.Spain
7.3.2.5.1.Spain Equine Healthcare market, by product type
7.3.2.5.2.Spain Equine Healthcare market, by diseases
7.3.2.5.3.Spain Equine Healthcare market, by distribution channel
7.3.2.6.Rest of Europe
7.3.2.6.1.Rest of Europe Equine Healthcare market, by product type
7.3.2.6.2.Rest of Europe Equine Healthcare market, by diseases
7.3.2.6.3.Rest of Europe Equine Healthcare market, by distribution channel
7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by diseases
7.3.5.Europe market size and forecast, by distribution channel
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.2.1.Japan
7.4.2.1.1.Japan Equine Healthcare market, by product type
7.4.2.1.2.Japan Equine Healthcare market, by diseases
7.4.2.1.3.Japan Equine Healthcare market, by distribution channel
7.4.2.2.China
7.4.2.2.1.China Equine Healthcare market, by product type
7.4.2.2.2.China Equine Healthcare market, by diseases
7.4.2.2.3.China Equine Healthcare market, by distribution channel
7.4.2.3.Australia
7.4.2.3.1.Australia Equine Healthcare market, by product type
7.4.2.3.2.Australia Equine Healthcare market, by diseases
7.4.2.3.3.Australia Equine Healthcare market, by distribution channel
7.4.2.4.India
7.4.2.4.1.India Equine Healthcare market, by product type
7.4.2.4.2.India Equine Healthcare market, by diseases
7.4.2.4.3.India Equine Healthcare market, by distribution channel
7.4.2.5.South Korea
7.4.2.5.1.South Korea Equine Healthcare market, by product type
7.4.2.5.2.South Korea Equine Healthcare market, by diseases
7.4.2.5.3.South Korea Equine Healthcare market, by distribution channel
7.4.2.6.Rest of Asia-Pacific
7.4.2.6.1.Rest of Asia-Pacific Equine Healthcare market, by product type
7.4.2.6.2.Rest of Asia-Pacific Equine Healthcare market, by diseases
7.4.2.6.3.Rest of Asia-Pacific Equine Healthcare market, by distribution channel
7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by diseases
7.4.5.Asia-Pacific market size and forecast, by distribution channel
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.2.1.Brazil
7.5.2.1.1.Brazil Equine Healthcare market, by product type
7.5.2.1.2.Brazil Equine Healthcare market, by diseases
7.5.2.1.3.Brazil Equine Healthcare market, by distribution channel
7.5.2.2.Saudi Arabia
7.5.2.2.1.Saudi Arabia Equine Healthcare market, by product type
7.5.2.2.2.Saudi Arabia Equine Healthcare market, by diseases
7.5.2.2.3.Saudi Arabia Equine Healthcare market, by distribution channel
7.5.2.3.South Africa
7.5.2.3.1.South Africa Equine Healthcare market, by product type
7.5.2.3.2.South Africa Equine Healthcare market, by diseases
7.5.2.3.3.South Africa Equine Healthcare market, by distribution channel
7.5.2.4.Rest of LAMEA
7.5.2.4.1.Rest of LAMEA Equine Healthcare market, by product type
7.5.2.4.2.Rest of LAMEA Equine Healthcare market, by diseases
7.5.2.4.3.Rest of LAMEA Equine Healthcare market, by distribution channel
7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by diseases
7.5.5.LAMEA market size and forecast, by distribution channel
CHAPTER 8:COMPANY PROFILES
8.1.Boehringer Ingelheim International GmbH
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Key strategic moves and developments
8.2.Ceva Santé Animale
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.3.Elanco Animal Health Inc. (Bayer Animal Health)
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.Equine Products UK LTD
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.Land O'Lakes, Inc. (Purina Mills, LLC)
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.MERCK & CO., INC.(Merck Animal Health)
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.Sanofi S.A. (Merial)
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.8.Thermo Fisher Scientific Inc. (Affymetrix Inc.)
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.9.Vetoquinol S.A.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.Zoetis Inc.
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.EQUINE HEALTHCARE MARKET, BY PRODUCT, 2020-2030 ($MILLION)
TABLE 02.EQUINE HEALTHCARE MARKET FOR DRUGS, BY REGION, 2020-2030 ($MILLION)
TABLE 03.EQUINE HEALTHCARE MARKET FOR VACCINES, BY REGION, 2020-2030 ($MILLION)
TABLE 04.EQUINE HEALTHCARE MARKET FOR MEDICATED FEED ADDITVES, BY REGION, 2020-2030 ($MILLION)
TABLE 05.EQUINE HEALTHCARE MARKET, BY DISEASES, 2020-2030 ($MILLION)
TABLE 06.EQUINE HEALTHCARE MARKET FOR INFLUENZA, BY REGION, 2020-2030 ($MILLION)
TABLE 07.EQUINE HEALTHCARE MARKET FOR TETANUS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.EQUINE HEALTHCARE MARKET FOR EQUINE HERPES VIRUS, BY REGION, 2020-2030 ($MILLION)
TABLE 09.EQUINE HEALTHCARE MARKET FOR OTHER DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 10.EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 11.EQUINE HEALTHCARE MARKET FOR VETERINARY HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.EQUINE HEALTHCARE MARKET FOR RETAIL PHARMACIES AND DRUG STORES, BY REGION, 2020-2030 ($MILLION)
TABLE 13.EQUINE HEALTHCARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 16.U.S. EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 17.U.S. EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 18.U.S. EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 19.CANADA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 20.CANADA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 21.CANADA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 22.MEXICO EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 23.MEXICO EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 24.MEXICO EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 25.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 28.EUROPE EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 29.GERMANY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 30.GERMANY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 31.GERMANY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 32.FRANCE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 33.FRANCE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 34.FRANCE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 35.UK EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 36.UK EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 37.UK EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 38.ITALY EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 39.ITALY EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 40.ITALY EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 41.SPAIN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 42.SPAIN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 43.SPAIN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 44.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 45.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 47.EUROPE EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 48.EUROPE EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 49.EUROPE EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 50.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 51.JAPAN EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 52.JAPAN EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 53.JAPAN EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 54.CHINA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 55.CHINA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 56.CHINA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 57.AUSTRALIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 58.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 59.AUSTRALIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 60.INDIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 61.INDIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 62.INDIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 63.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 64.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 69.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 72.LAMEA EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 73.BRAZIL EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 74.BRAZIL EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 75.BRAZIL EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 76.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 79.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 82.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 85.LAMEA EQUINE HEALTHCARE MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 86.LAMEA EQUINE HEALTHCARE MARKET, BY DISEASES, 2020–2030 ($MILLION)
TABLE 87.LAMEA EQUINE HEALTHCARE MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 88.BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
TABLE 89.BOEHRINGER INGELHEIM: OPERATING SEGMENTS
TABLE 90.BOEHRINGER INGELHEIM: PRODUCT PORTFOLIO
TABLE 91.BOEHRINGER INGELHEIM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.CEVA SANTÉ: COMPANY SNAPSHOT
TABLE 93.CEVA SANTÉ: OERATING SEGMENT
TABLE 94.CEVA SANTÉ: PRODUCT PORTFOLIO
TABLE 95.ELANCO: COMPANY SNAPSHOT
TABLE 96.ELANCO: OPERATING SEGMENTS
TABLE 97.ELANCO: PRODUCT PORTFOLIO
TABLE 98.ELANCO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.EQUINE PRODUCTS: COMPANY SNAPSHOT
TABLE 100.EQUINE PRODUCTS: OPERATING SEGMENTS
TABLE 101.EQUINE PRODUCTS: PRODUCT PORTFOLIO
TABLE 102.EQUINE PRODUCTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.LAND O'LAKES: COMPANY SNAPSHOT
TABLE 104.LAND O'LAKES: OPERATING SEGMENTS
TABLE 105.LAND O'LAKES: PRODUCT PORTFOLIO
TABLE 106.MERCK: COMPANY SNAPSHOT
TABLE 107.MERCK: OPERATING SEGMENTS
TABLE 108.MERCK: PRODUCT PORTFOLIO
TABLE 109.SANOFI: COMPANY SNAPSHOT
TABLE 110.SANOFI: OERATING SEGMENT
TABLE 111.SANOFI: PRODUCT PORTFOLIO
TABLE 112.THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 113.THERMO FISHER SCIENTIFIC: OERATING SEGMENT
TABLE 114.THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 115.VETOQUINOL: COMPANY SNAPSHOT
TABLE 116.VETOQUINOL: OPERATING SEGMENTS
TABLE 117.VETOQUINOL: PRODUCT PORTFOLIO
TABLE 118.ZOETIS: COMPANY SNAPSHOT
TABLE 119.ZOETIS: OPERATING SEGMENTS
TABLE 120.ZOETIS: PRODUCT PORTFOLIO
TABLE 121.ZOETIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.GLOBAL EQUINE HEALTHCARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 01.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02.MODERATE BARGAINING POWER OF BUYERS
FIGURE 03.HIGH THREAT OF SUBSTITUTES
FIGURE 04.MODERATE THREAT OF NEW ENTRANTS
FIGURE 05.HIGH INTENSITY OF RIVALRY
FIGURE 06.TOP PLAYER POSITIONING, 2020
FIGURE 07.IMPACT ANALYSIS
FIGURE 08.COMPARATIVE ANALYSIS OF DRUGS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020 & 2030 (%)
FIGURE 09.ANTI-INFECTIVES DRUGS, 2020–2030, ($MILLION)
FIGURE 10.ANTI-INFLAMMATORY DRUGS MARKET, 2020–2030, ($MILLION)
FIGURE 11.PARASITICIDE DRUGS MARKET, 2020–2030, ($MILLION)
FIGURE 12.OTHER DRUGS MARKET, 2020–2030, ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF VACCINES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 ($MILLION)
FIGURE 14.INACTIVATED VACCINES MARKET, 2020–2030, ($MILLION)
FIGURE 15.LIVE ATTENUATED VACCINE MARKET, 2020–2030, ($MILLION)
FIGURE 16.RECOMBINANT VACCINE MARKET, 2020–2030, ($MILLION)
FIGURE 17.OTHER VACCINE MARKET, 2020–2030, ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF MEDICATED FEED ADDITIVES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF INFLUENZA EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF TETANUS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF EQUINE HERPES VIRUS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF OTHER DISEASES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020- 2030 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF VETERINARY HOSPITALS AND CLINICS EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF RETAIL PHARMACIES AND DRUG STORES EQUINE HEALTHCARE MARKET, BY COUNTRY, 2020-2030 (%)
FIGURE 25.ELANCO: NET SALES, 2018–2020 ($MILLION)
FIGURE 26.ELANCO: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 28.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 30.SANOFI: NET SALES, 2018–2020 ($MILLION)
FIGURE 31.SANOFI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.SANOFI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 33.THERMO FISHER SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 34.THERMO FISHER SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.THERMO FISHER SCIENTIFIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36.VETOQUINOL: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.ZOETIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.ZOETIS: REVENUE SHARE BY REGION, 2020 (%)
Horse is a majestic animal and a responsible owner should provide it with quality care and attention. Many horse owners think of consulting veterinarian only in emergency situations and don’t consider obtaining information or advice regarding day-to-day health care, including nutrition and medication. All horses need vaccinations and regular deworming. Vaccination recommendations vary based on age, the amount the horse travels, and location. The equine industry focuses on the needs of horse healthcare for horse owners and caretakers ranging from leisure horses to Olympic competitors. The equine healthcare market is expected to grow during the forecast period, owing to rise in prevalence of equine diseases, increase in equine population, surge in animal health expenditure, surge in demand for use of horses for various purposes, increase in advancements of equine healthcare products, rise in awareness among the population about the importance and benefits of horses healthcare, and escalation in demand for pet insurance. However, decline in equine population is expected to hamper the market growth.
The use of equine healthcare is highest in North America, owing to factors such as rise in health awareness among population and ease of availability of veterinary services. Although the use of equine healthcare in Europe and LAMEA is low, the adoption rate is expected to increase, owing to increase in target population and launch of new products.
A. The total market value of Equine Healthcare market is $2,329 million in 2030.
A. The forcast period for Equine Healthcare market is 2020 to 2030
A. The market value of Equine Healthcare market in 2020 is $1,207 million.
A. The base year is 2020 in Equine Healthcare market
A. Top companies such as Boehringer Ingelheim, EQUINE PRODUCTS UK LTD, Zoetis, Elanco Animal Health (Bayer Animal Health), Land O'Lakes, Inc.(Purina Mills LLC) held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Drugs segment is the most influencing segment owing to rise in demand for pet insurance, surge in awareness towards effective & advanced drugs and vaccines, rise in number of cases of equine diseases may lead to increase in hospital admissions, and the launch of effective products, which are tested under clinical trials by the companies, ensure better therapeutic outcomes.
A. New product launch and companies acquisions owing to rise in demand for pet insurance, surge in awareness towards effective & advanced drugs and vaccines, rise in number of cases of equine diseases may lead to increase in hospital admissions, and the launch of effective products, which are tested under clinical trials by the companies, ensure better therapeutic outcomes.
A. North America has the highest growth rate in the market which is growing due to increase in healthcare expenditure and surge in patient population in the region contribute toward the growth of the market.
A. Yes, the Equine Healthcare Market company is profiled in the report.
A. Yes, the Equine Healthcare Market report provides PORTER Analysis
Start reading instantly.
This Report and over 68,378+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report